GREAT WEST LIFE ASSURANCE CO /CAN/ - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
GREAT WEST LIFE ASSURANCE CO /CAN/ ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,233
-14.8%
20,635
+2.8%
0.00%0.0%
Q2 2023$1,448
+8.1%
20,082
+10.2%
0.00%0.0%
Q1 2023$1,339
+2.2%
18,231
-7.1%
0.00%0.0%
Q4 2022$1,310
-99.9%
19,624
-4.6%
0.00%
-40.0%
Q3 2022$1,771,000
+19.6%
20,570
+23.6%
0.01%
+25.0%
Q2 2022$1,481,000
-10.6%
16,644
+15.7%
0.00%
+33.3%
Q1 2022$1,657,000
-25.7%
14,386
-0.7%
0.00%
-40.0%
Q4 2021$2,231,000
+9.1%
14,484
-0.6%
0.01%0.0%
Q3 2021$2,044,000
+144.5%
14,574
+128.5%
0.01%
+150.0%
Q2 2021$836,000
-13.9%
6,3790.0%0.00%0.0%
Q1 2021$971,000
+40.5%
6,379
-8.2%
0.00%
+100.0%
Q4 2020$691,000
-5.2%
6,949
-9.4%
0.00%
-50.0%
Q3 2020$729,000
-19.8%
7,667
-5.7%
0.00%0.0%
Q2 2020$909,000
+47.8%
8,130
-4.2%
0.00%0.0%
Q1 2020$615,000
-31.4%
8,489
-2.0%
0.00%0.0%
Q4 2019$896,000
-34.4%
8,663
-27.6%
0.00%
-33.3%
Q2 2019$1,365,000
-13.7%
11,965
-4.9%
0.00%
-25.0%
Q1 2019$1,581,000
-2.0%
12,582
-1.8%
0.00%
-20.0%
Q4 2018$1,613,000
-77.8%
12,813
-51.5%
0.01%
-70.6%
Q3 2018$7,250,000
+28.6%
26,425
-2.9%
0.02%
+30.8%
Q2 2018$5,639,000
+21.7%
27,222
-3.0%
0.01%
+18.2%
Q1 2018$4,635,000
+21.7%
28,062
+0.9%
0.01%
+22.2%
Q4 2017$3,808,000
+0.1%
27,817
-1.6%
0.01%0.0%
Q3 2017$3,805,000
+13.3%
28,265
+2.2%
0.01%0.0%
Q2 2017$3,359,000
+18.8%
27,666
+3.6%
0.01%
+12.5%
Q1 2017$2,827,000
+10.5%
26,716
+6.1%
0.01%
+14.3%
Q4 2016$2,558,000
-51.0%
25,169
-50.8%
0.01%
-12.5%
Q3 2016$5,218,000
+77.1%
51,132
+106.8%
0.01%
-11.1%
Q2 2016$2,947,000
+1215.6%
24,724
+1078.5%
0.01%
+800.0%
Q1 2016$224,000
+52.4%
2,098
+55.3%
0.00%0.0%
Q4 2015$147,000
+26.7%
1,3510.0%0.00%
Q3 2015$116,000
-14.7%
1,3510.0%0.00%
Q2 2015$136,000
+30.8%
1,3510.0%0.00%
Q1 2015$104,000
+44.4%
1,3510.0%0.00%
Q4 2014$72,000
+12.5%
1,3510.0%0.00%
Q3 2014$64,000
-23.8%
1,3510.0%0.00%
Q2 2014$84,000
-6.7%
1,3510.0%0.00%
Q1 2014$90,000
+25.0%
1,3510.0%0.00%
Q4 2013$72,0001,3510.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$12,937,0004.12%
Stonepine Capital Management, LLC 73,700$8,291,0003.44%
VILLERE ST DENIS J & CO LLC 510,843$57,464,0003.41%
Chicago Capital, LLC 491,717$55,313,0002.38%
Orchard Capital Management, LLC 73,596$8,279,0002.35%
RICE HALL JAMES & ASSOCIATES, LLC 344,969$38,806,0001.55%
Smith, Graham & Co., Investment Advisors, LP 86,834$9,768,0001.02%
WOODSTOCK CORP 64,050$7,205,0000.84%
INVESTMENT MANAGEMENT OF VIRGINIA LLC 37,246$4,190,0000.74%
Stephens Investment Management Group LLC 417,670$46,984,0000.69%
View complete list of LIGAND PHARMACEUTICALS INC shareholders